Artificial Intelligence Published on December 2, 2019 Diagnos Inc., a Montreal leader in the early detection of serious health problems through its artificial intelligence technology, announces the appointment of Mr. Francis Bellido as a member of the Board of Directors of the Corporation. He has, over the course of his career, managed a $ 300 million life sciences investment fund that has produced several great players in the medical device industry. (french content) Read more
Artificial Intelligence Published on December 2, 2019 December 2018, exactly 1 year ago, marked the launch of the Montreal Declaration for Responsible Development of Artificial Intelligence (AI) and the creation of the International Observatory on the Societal Impacts of Artificial Intelligence and Information Technology. digital (OIISIAN). Widely acclaimed on the international scene, these initiatives have consolidated Quebec’s leadership role in the ethical development of AI. (french content) Read more
Business environment Published on December 2, 2019 The Public Sector Pension Investment Board (PSP) – one of the largest fund managers for pension funds in the country – has just disclosed in a document filed with the Securities and Exchange Commission that its largest shareholding in the stock market is now its investment in Avantor, a supplier of equipment and chemicals for the life sciences sector. (french content) Read more
Business environment Published on November 29, 2019 The Université de Sherbrooke ranks 15th among the top research universities in Canada, a solid position that the institution attributes to the tenacity, know-how and diligence of its teams of researchers. (french content) Read more
Medtech Published on November 29, 2019 The Jacques-Rousseau Award from the Association francophone pour le savoir (Acfas) celebrating multidisciplinarity is awarded to Roger Lecomte, professor-researcher at the Faculty of Medicine and Health Sciences at the Université de Sherbrooke and at the Research Center of the CHUS. Professor Lecomte has transformed the field of biomedical imaging used as a research tool. (french content) Read more
Pharma Published on November 29, 2019 ExCellThera Inc., an advanced Montreal biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that data from a Phase I/II clinical trial using its lead technology, ECT-001, will be presented at the 61st Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida. Read more
Business environment Published on November 29, 2019 Two Sherbrooke companies were honored at the prestigious MercadOr 2019 export awards gala. The pharmaceutical research company Diex Recherche won the Export Value-Added Services Award. Coveo won the Export of the Year title and won the Export Leader award. (french content) Read more
R&D Published on November 29, 2019 Dr. Claudia Kleinman of the Lady Davis Institute at the Montreal Jewish General Hospital, Dr. Nada Jabado of the Research Institute of the McGill University Health Center, and their colleagues discovered that certain brain cells – while they are still very young and immature – cease to develop normally and become tumors. This genetic anomaly would occur early in cell development, possibly even before birth. (french content) Read more
R&D Published on November 29, 2019 The Maisonneuve-Rosemont Hospital (HMR), part of the CIUSSS of the East-Island of Montreal, is home to one of the world’s largest stem cell research centers. They are developing cutting-edge therapies that are already changing and saving lives, and that are revolutionizing the way we treat, and even cure, serious or incurable diseases – cancer in particular. (french content) Read more